Publications by authors named "Maria Vadiaka"

Claim this Profile
M
Multiple mononeuritis with peripheral blood eosinophilia in a patient with Q fever: An unusual presentation: Case report and review of the literature.
Dimitris Kounatidis, Alexandros Skourtis, Eugenia Grivakou, Christina Vourlakou, Eleni Geladari, Maria Vadiaka

J Infect Chemother· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coexistence of Hodgkin and Non-Hodgkin Lymphoma; Composite Lymphoma [CL] in a Patient Presenting with Waxing and Waning Lymphadenopathy.
Eleni Geladari, Georgia Dimopoulou, Evangelia Margellou, Andreas Paraskevas, Georgios Kafetzis, Maria Vadiaka

Cardiovasc Hematol Disord Drug Targets· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clostridioides difficile infection in a patient with immunoglobulin A vasculitis: a triggering factor or a rare complication of the disease? A case-based review.
Dimitris Kounatidis, Maria Vadiaka, Charikleia Kouvidou, Dimitrios Sampaziotis, Alexandros Skourtis

Rheumatol Int· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low dose dabigatran versus uninterrupted acenocoumarol for peri-procedural anticoagulation in atrial fibrillation catheter ablation.
Michael Efremidis, Konstantinos Vlachos, Konstantinos P Letsas, Georgios Giannopoulos, Louiza Lioni, Maria Vadiaka

J Electrocardiol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of atrial fibrillation recurrence in patients with long-lasting atrial fibrillation.
Michalis Efremidis, Ioannis P Alexanian, Dimitrios Oikonomou, Dimitrios Manolatos, Konstantinos P Letsas, Maria Vadiaka

Can J Cardiol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of two oral regimens for the outpatient treatment of low-risk cancer patients with chemotherapy-induced neutropenia and fever: ciprofloxacin plus cefuroxime axetil versus ciprofloxacin plus amoxicillin/clavulanate.
Nikolaos V Sipsas, Christos Kosmas, Panayiotis D Ziakas, Athanasios Karabelis, Maria Vadiaka

Scand J Infect Dis· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analgesic activity of high-dose intravenous calcitonin in cancer patients with bone metastases.
Nicolas Tsavaris, Petros Kopterides, Christos Kosmas, Maria Vadiaka, Antonios Dimitrakopoulos

Oncol Rep· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A simplified premedication schedule for 1-hour paclitaxel administration.
Nicolas Tsavaris, Christos Kosmas, Maria Vadiaka

J Support Oncol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel and epirubicin supported by granulocyte colony-stimulating factor first-line in advanced breast cancer.
Aristides Polyzos, Nicholas Tsavaris, Christos Kosmas, Helen Gogas, Maria Vadiaka

Anticancer Res· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amifostine, in a reduced dose, protects against severe diarrhea associated with weekly fluorouracil and folinic acid chemotherapy in advanced colorectal cancer: a pilot study.
Nicolas Tsavaris, Christos Kosmas, Maria Vadiaka, Dimitris Zonios, Efstathios Papalambros

J Pain Symptom Manage· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Raltitrexed (Tomudex) administration in patients with relapsed metastatic colorectal cancer after weekly irinotecan/5-Fluorouracil/Leucovorin chemotherapy.
Nicolas Tsavaris, Christos Kosmas, Maria Vadiaka, Christos Koufos

BMC Cancer· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegylated liposomal doxorubicin in the CHOP regimen for older patients with aggressive (stages III/IV) non-Hodgkin's lymphoma.
Nikolas Tsavaris, Christos Kosmas, Maria Vadiaka, Stavroula Giannouli, Marina P Siakantaris

Anticancer Res· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etoposide added to weekly leucovorin (LV)/5-fluorouracil (5-FU) in LV/5-FU pre-treated patients with advanced colorectal cancer.
Nicolas Tsavaris, Christos Kosmas, Kostas Gennatas, Maria Vadiaka, Platon Paliaros

Med Sci Monit· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients.
Nicolas Tsavaris, Christos Kosmas, Maria Vadiaka, Michalis Efremidis, Andreas Zinelis

Med Sci Monit· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I-II study of docetaxel-ifosfamide-cisplatin (DIP) combination chemotherapy regimen in advanced nonsmall cell lung cancer.
Christos Kosmas, Nicolas B Tsavaris, Thomas Makatsoris, Adimchi Onyenadum, Maria Vadiaka

Int J Cancer· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis